Hjem › Kreft (alle typer) › South Dakota
Kliniske studier for Kreft (alle typer) i South Dakota
13 studier for Kreft (alle typer) søker deltakere på steder i South Dakota.
Byer i South Dakota
Offisiell studietekst (engelsk)
A Study of Ifinatamab Deruxtecan in Pediatric Participants With Relapsed or Refractory Solid Tumors (MK-9999-01D/LIGHTBEAM-U01)
- Sanford Children's Hospital ( Site 4015), Sioux Falls
RekruttererFase 1/2
1 Month – 17 Years · Alle kjønn · Oppdatert 25. sep. 2026 · NCT07630974TAPUR: Testing the Use of Food and Drug Administration (FDA) Approved Drugs That Target a Specific Abnormality in a Tumor Gene in People With Advanced Stage Cancer
- Sanford Cancer Center Oncology Clinic and Pharmacy, Sioux Falls
RekruttererFase 2
Alder 12 og eldre · Alle kjønn · Oppdatert 22. sep. 2026 · NCT02693535Connect for Cancer Prevention Study (Connect)
- Sanford Health, Sioux Falls
RekruttererObservasjonsstudieFrivillige helsepersonell ønskes velkommen
Alder 30 til 70 · Alle kjønn · Oppdatert 17. sep. 2026 · NCT04609072A Study of Patritumab Deruxtecan in Pediatric Participants With Relapsed or Refractory Solid Tumors (MK-9999-01C/LIGHTBEAM-U01)
- Sanford Children's Hospital ( Site 3015), Sioux Falls
RekruttererFase 1/2
1 Month – 17 Years · Alle kjønn · Oppdatert 17. sep. 2026 · NCT06941272A Phase IIIb Study to Evaluate Camizestrant Plus Ribociclib in ER-positive, HER2-negative Advanced Breast Cancer
- Research Site, Sioux Falls
RekruttererFase 3
Alder 18 til 130 · Alle kjønn · Oppdatert 8. sep. 2026 · NCT07647328A Longitudinal Multi-Omic Biomarker Profiling Study of Patients With Head & Neck Squamous Cell Carcinoma (HNSCC)
- Sanford Sioux Falls, Sioux Falls
RekruttererObservasjonsstudie
Alder 18 og eldre · Alle kjønn · Oppdatert 3. sep. 2026 · NCT06163534KEYMAKER-U01 Substudy 01J: A Study of Pembrolizumab Plus MK-1084 in Participants With Non-Small Cell Lung Cancer (NSCLC) With Kirsten Rat Sarcoma Viral Oncogene Homolog (KRAS) G12C Mutations (MK-3475-01J/KEYMAKER-U01J)
- Sanford Cancer Center Oncology Clinic ( Site 0038), Sioux Falls
RekruttererFase 2
Alder 18 og eldre · Alle kjønn · Oppdatert 2. sep. 2026 · NCT07252739Project: Every Child for Younger Patients With Cancer
- Sanford USD Medical Center - Sioux Falls, Sioux Falls
RekruttererObservasjonsstudie
Opp til 25 år · Alle kjønn · Oppdatert 25. aug. 2026 · NCT02402244Testing Olaparib for One or Two Years, With or Without Bevacizumab, to Treat Ovarian Cancer
- Avera Cancer Institute-Aberdeen, Aberdeen
- Avera Cancer Institute - Mitchell, Mitchell
- Avera Cancer Institute at Pierre, Pierre
- og 4 flere
RekruttererFase 3
Alder 18 og eldre · Alle kjønn · Oppdatert 7. aug. 2026 · NCT06580314Study of Trastuzumab Deruxtecan Versus Standard of Care Chemotherapy for HER2-Expressing (IHC 3+/2+) Endometrial Cancer
- Avera Medical Group Gynecologic Oncology Sioux Falls, Sioux Falls
- Texas Oncology, P.A. - Tyler, Sioux Falls
RekruttererFase 3
Alder 18 og eldre · Kvinner · Oppdatert 28. jul. 2026 · NCT07022483I-SPY TRIAL: Neoadjuvant and Personalized Adaptive Novel Agents to Treat Breast Cancer
- Sanford Clinical Research, Sioux Falls
RekruttererFase 2
Alder 18 og eldre · Alle kjønn · Oppdatert 6. mai 2026 · NCT01042379Avera Cancer Sequencing and Analytics Protocol (ASAP)
- Avera Cancer Institute - Aberdeen, Aberdeen
- Avera Cancer Institute - Mitchell, Mitchell
- Avera Cancer Institute - Pierre, Pierre
- og 2 flere
RekruttererObservasjonsstudie
Alder 18 og eldre · Alle kjønn · Oppdatert 27. mar. 2026 · NCT05142033Melanoma Margins Trial-II: 1cm v 2cm Wide Surgical Excision Margins for AJCC Stage II Primary Cutaneous Melanoma
- Sanford Cancer Center Oncology Clinic, Sioux Falls
- Sanford USD Medical Center - Sioux Falls, Sioux Falls
Rekrutterer
Alder 18 og eldre · Alle kjønn · Oppdatert 27. nov. 2024 · NCT03860883Fra ClinicalTrials.gov, data hentet 5. okt. 2026. Hver studie setter sine egne kvalifikasjonskrav; studieteamet avgjør hvem som kan delta.